A pharmaceutical company based in the Indian city of Mumbai said on Tuesday (Sep 3) that it received approval from the Drug Controller General of India (DCGI) to market eye drops for the treatment of presbyopia.

A pharmaceutical company based in the Indian city of Mumbai said on Tuesday (Sep 3) that it received approval from the Drug Controller General of India (DCGI) to market eye drops for the treatment of presbyopia. Entod Pharmaceuticals said it received final approval for PresVu eye drops and plans to introduce them in the domestic market in the first week of October. A report by the news agency PTI said that the DCGI approval follows an earlier recommendation by the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO). PresVu will reduce dependency on reading glasses PresVu is the first eye drop in India that has been specifically developed to reduce dependency on reading glasses for people affected by presbyopia. Also read | Worms that live in eyes and are transmitted by flies can reach humans, experts fear According to Mayo Clinic, presbyopia is the gradual loss of your eye's ability to focus on nearby objects. The condition usually becomes noticeable in your early to mid-40s and continues to worsen until around age 65. Mayo Clinic says that presbyopia can be corrected with eyeglasses, contact lenses or even surgery. Citing industry stands, the PTI report on Tuesday said that 1.09-1.8 billion individuals globally are estimated to be affected by presbyopia. 'PresVu is more than just a product' Speaking to PTI, Entod Pharmaceuticals' Chief Executive Officer (CEO) Nikkhil K Masurkar said that the DCGI approval was a major step forward in the company's mission to transform eye care in India. "PresVu is more than just a product; it's a solution that stands to improve the lives of millions by offering them greater visual independence," Masurkar added. Asked about the company's future plans, Masurkar said the focus would be to cater to demand in domestic and emerging markets like Africa and South East Asia. He also pointed out that the company aimed to innovate products in India and then out-licence them in the US market. (With inputs from agencies)

Eye drops to reduce dependency on reading glasses to hit Indian market soon

entod-pharmaceuticals

Entod Pharmaceuticals, News on Entod Pharmaceuticals, stories on Entod Pharmaceuticals, articles on Entod Pharmaceuticals, Entod Pharmaceuticals stories at Wion, Entod Pharmaceuticals news, Entod Pharmaceuticals latest news

entod pharmaceuticals

Eye drops to reduce dependency on reading glasses to hit Indian market soon